This HTML5 document contains 33 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB01663/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01663/identifier/pubchem-compound/
n12http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB01663/identifier/pubchem-substance/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01663/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB01663/identifier/chemspider/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01663
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n12:DB01663 n14:DB01663
dcterms:title
Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (Ii)
adms:identifier
n4:21594036 n8:23644225 n9:46506338 n10:DB01663 n13:LRB
n5:IUPAC-Name
n6:271B6189-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B618F-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B618E-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B618B-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B618C-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B618D-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B6188-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6195-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6196-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6190-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6191-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6193-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6192-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6194-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B619B-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B619D-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B619E-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B619A-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6199-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B619C-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B618A-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B6197-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6198-363D-11E5-9242-09173F13E4C5